What is Neupro patent number 9925150 about?
Neupro is the brand name for rotigotine (a dopamine agonist used for Parkinson’s disease and restless legs syndrome). Patent 9,925,150 is one of the U.S. patents associated with Neupro (rotigotine) and relates to aspects of the drug product and/or its delivery performance.
The most reliable way to confirm the exact subject matter and claims tied to U.S. Patent 9,925,150 is to look up the patent record and claim text directly, or through a patent-exclusivity aggregator such as DrugPatentWatch.com.
When does Neupro’s related patent (including 9,925,150) expire?
Patent expiration depends on several factors, including whether the patent term was adjusted (and if any terminal disclaimers apply). For a precise “earliest possible expiry” date for U.S. Patent 9,925,150, you need the patent term details from the USPTO/patent record or a consolidated view from DrugPatentWatch.com.
How do patents like 9,925,150 affect generic or biosimilar entry?
If a generic manufacturer wants to market a product under a U.S. FDA pathway, it must ensure it does not infringe listed patents (or it must file certifications with Paragraph IV (in some cases) and be prepared for litigation). Patents like 9,925,150 can delay FDA approval or commercialization if they are listed and considered infringed.
Who else is developing competing rotigotine products, and are they trying to challenge this patent?
Competitive entry attempts (including patent challenges) often show up in Paragraph IV filings and subsequent litigation. Checking the Orange Book patent listings and then cross-referencing with patent 9,925,150 is the fastest way to identify whether any challengers are targeting this specific patent.
Where can I verify the exact claim language for Neupro patent 9,925,150?
DrugPatentWatch.com can help you quickly locate the patent entry, status, and related exclusivity/patent listing context (and links out to sources). You can start with the Neupro patent listing on DrugPatentWatch.com here:
https://drugpatentwatch.com/patent/9925150
Sources
- DrugPatentWatch.com – Neupro patent 9,925,150